Stockholders' Deficiency (Details Narrative) - USD ($)																							3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 12, 2018	Dec. 29, 2017	Dec. 22, 2017	Dec. 21, 2017	Dec. 13, 2017	Dec. 09, 2017	Dec. 09, 2017	Nov. 29, 2017	Oct. 25, 2017	Oct. 05, 2017	Sep. 28, 2017	Sep. 27, 2017	Aug. 29, 2017	Mar. 28, 2017	Mar. 10, 2017	Jan. 17, 2017	Mar. 31, 2016	Sep. 30, 2015	Aug. 18, 2015	Aug. 18, 2015	Mar. 18, 2014	Aug. 10, 2012	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017	Apr. 05, 2018	Dec. 31, 2016
Common stock, shares authorized																							65,000,000		65,000,000		65,000,000
Common stock, shares designated																							65,000,000		65,000,000
Common stock, par value																							$ 0.001		$ 0.001		$ 0.001
Preferred stock, shares designated																							5,000,000		5,000,000
Preferred stock, par value																							$ 0.001		$ 0.001
Stockholders' deficiency																							$ 5,359,154		$ 5,359,154		$ 4,355,384
Preferred stock, shares authorized																							5,000,000		5,000,000
Preferred stock voting																									Cumulative Convertible Preferred Stock (non-voting, “9% Preferred Stock”)
Common stock, shares outstanding																						443,205	3,588,433		3,588,433		3,065,261
Common stock available for future issuances																							8,845,013		8,845,013
Offering of common stock							$ 2,475,561																		$ 195,750
Proceeds from issuance of common stock																									$ 200,750	$ 476,000
Debt conversion, shares issued																									16,061
Common stock purchase of warrants																								8,000		8,000
Debt instrument interest rate																							8.93%		8.93%
Purchase price per share																						$ 18.2000						$ 1.12
Warrants, exercise price																								$ 2.75		$ 2.75
Fair value of market price per share																							$ 1.00	$ 1.40	$ 1.00	$ 1.40
Stock warrant intrinsic value of exercisable																								$ 144,633		$ 144,633
Share granted during period																									327,150	739,000
Stock option period																										4 years 99 months 29 days
Common stock fixed price per shares																							$ 1.00	$ 2.00	$ 1.00	$ 2.00
Stock-based compensation expense							$ 2,557,083
Sold units for aggregate cash consideration																						179,747
Fair value of common stock																						$ 3,271,402
Percentage of common stock issued																						41.00%
Issue additional contingent consideration																						56,351
Common stock, shares issued																							3,588,433		3,588,433		3,065,261
Number of warrants, outstanding, exercisable																							1,703,229	985,915	1,703,229	985,915	1,464,415		540,198
Debt instrument conversion into shares																									16,061
Number of common stock shares unreserved for future issuance																							52,566,553		52,566,553
Pier Merger Agreement [Member]
Issuance of contingent shares of common stock																									6,497
General and Administrative Expense [Member]
Stock-based compensation expense																									$ 14,248	$ 1,150,925
Research and Development Member [Member]
Stock-based compensation expense																									$ 0	606,901
2014 Equity Plan [Member]
Share granted during period																					325,025
2018 Unit Offering [Member]
Preferred stock shares issuable upon conversion, per share	$ 1.05
Offering of common stock	$ 1,500,000
Initial closing amount	250,750
Proceeds from issuance of common stock	$ 200,750
Debt conversion, shares issued	50,000
Sales price per share	$ 1.05
Warrants exercisable date	Apr. 30, 2023
Purchase price, percentage	150.00%
Redemption of warrants price per share	$ 0.001
Common stock purchase of warrants	238,814
Warrant description	The warrants are also subject to redemption by the Company at $0.001 per share upon ten (10) days written notice if the Company’s common stock closes at $3.00 or more for any five (5) consecutive trading days. In total, 238,814 shares of the Company’s common stock and 238,814 common stock purchase warrants were purchased.
Debt instrument principal amount	$ 100,000
Debt instrument interest rate	10.00%
Gross proceeds	$ 15,000,000
Warrant exercisable date	Apr. 30, 2023
Percentage of investor beneficially outstanding shares of common stock	4.99%
Debt instrument conversion into shares	50,000
Board of Directors [Member]
Preferred stock, shares undesignated																							3,505,800		3,505,800		3,505,800
Board of Directors [Member] | 2015 Stock and Stock Option Plan [Member]
Option issued to purchase number of common stock																		461,538
Stock option period																		10 years
Board of Directors [Member] | 2015 Equity Plan [Member]
Share granted during period						6,985,260										3,038,461	1,538,461			769,231
Board of Directors [Member] | 2015 Stock and Stock Option Plan [Member]
Share granted during period																1,500,000
Board of Directors [Member] | 2015 Stock and Stock Option Plan [Member] | Minimum [Member]
Share granted during period																1,538,461
Board of Directors [Member] | 2015 Stock and Stock Option Plan [Member] | Maximum [Member]
Share granted during period																3,038,461
Board of Directors [Member] | 2015 Stock and Stock Option Plan [Member]
Share granted during period						6,985,260
Dr. Arnold S.Lippa [Member]
Stock-based compensation expense																			$ 300,000				$ 84,900	$ 84,900	$ 254,700	$ 169,800
Dr. Arnold S.Lippa [Member] | 2018 Unit Offering [Member]
Debt instrument principal amount	$ 50,000
Dr. James S. Manuso [Member] | 2018 Unit Offering [Member]
Debt instrument principal amount	$ 50,000
Officer and Director [Member]
Share granted during period																						22,651
Stock options exercise price																						$ 19.5000
Series B Convertible Preferred Stock [Member]
Preferred stock, shares designated																							37,500		37,500		37,500
Preferred stock, par value																							$ 0.001		$ 0.001		$ 0.001
Stockholders' deficiency																							$ (21,703)		$ (21,703)		$ (21,703)
Preferred stock, shares authorized																							37,500		37,500		37,500
Preferred stock shares issuable upon conversion, per share																							$ 0.00030		$ 0.00030		$ 0.00030
Debt instrument, conversion price per share																							$ 2,208.375		$ 2,208.375		$ 2,208.375
Preferred stock shares issuable upon conversion																							11		11		11
Preferred stock redemption amount																							$ 25,001		$ 25,001		$ 25,001
Redeemed preferred stock price per share																							$ 0.6667		$ 0.6667		$ 0.6667
Preferred stock conversion into common stock description																									Each share of Series B Preferred Stock is convertible into approximately 0.00030 shares of common stock at an effective conversion price of $2,208.375 per share of common stock, which is subject to adjustment under certain circumstances.		Each share of Series B Preferred Stock is convertible into approximately 0.00030 shares of common stock at an effective conversion price of $2,208.375 per share of common stock, which is subject to adjustment under certain circumstances.
Offering of common stock
Sales price per share																							$ 0.00030		$ 0.00030		$ 0.00030
Series B Convertible Preferred Stock [Member] | Stock Option [Member]
Conversion of stock																									4,323,317
Series B Convertible Preferred Stock [Member] | 2014 Plan [Member]
Common stock available for future issuances																							63,236		63,236
Series B Convertible Preferred Stock [Member] | 2015 Plan [Member]
Common stock available for future issuances																							2,732,662		2,732,662
Series A Junior Participating Preferred Stock [Member]
Preferred stock, shares designated																							205,000		205,000		205,000
Series G 1.5% Convertible Preferred Stock [Member]
Preferred stock, shares designated																							1,700		1,700		1,700
9% Cumulative Convertible Preferred Stock [Member]
Preferred stock, shares designated																							1,250,000		1,250,000		1,250,000
Common Stock [Member]
Stockholders' deficiency																							$ (3,588)		$ (3,588)		$ (3,065)
Common stock, shares outstanding																							3,588,434		3,588,434
Common stock available for future issuances																							52,566,553		52,566,553
Offering of common stock																									$ 191
1st 2017 Unit Offering [Member] | Aurora Capital LLC [Member]
Cash placement agent fees																									$ 20,000
Number of warrant shares fee																									8,000
Additional paid in capital warrants																									$ 27,648
1st 2017 Unit Offering [Member] | Investors [Member]
Common stock, par value																							$ 0.001		$ 0.001
Warrants exercisable date																									Dec. 31, 2021
Gross proceeds														$ 350,000	$ 350,000										$ 15,000,000
Purchase price per share																							2.50		$ 2.50
Warrant exercisable date																									Dec. 31, 2021
Warrants, exercise price																							$ 2.75		$ 2.75
Percentage of investor beneficially outstanding shares of common stock																							4.99%		4.99%
Percentage of unit purchase price																							200.00%		200.00%
1st 2017 Unit Offering [Member] | Subsequent Equity Financing [Member]
Purchase price per share														$ 3.80	$ 4.05
2nd 2017 Unit Offering [Member] | Investors [Member]
Common stock, par value																							$ 0.001		$ 0.001
Warrants exercisable date																									Sep. 29, 2022
Gross proceeds		$ 404,500	$ 404,500	$ 404,500	$ 404,500			$ 404,500	$ 404,500	$ 404,500	$ 404,500	$ 404,500	$ 404,500												$ 15,000,000
Purchase price per share		$ 1.14	$ 1.45	$ 1.51	$ 1.45			$ 1.05	$ 0.80	$ 1.50	$ 1.40	$ 1.40	$ 1.00										1.00		$ 1.00
Warrant exercisable date																									Sep. 29, 2022
Warrants, exercise price																							$ 1.10		$ 1.10
Percentage of investor beneficially outstanding shares of common stock																							4.99%		4.99%
Percentage of unit purchase price																							250.00%		250.00%
Warrants description																									The warrants are also subject to redemption by the Company at $0.001 per share upon ten (10) days written notice if the Company's common stock closes at 250% or more of the unit purchase price for any five (5) consecutive trading days.